TCRR / Tcr2 Therapeutics Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Tcr2 Therapeutics Inc
US ˙ NASDAQ ˙ US87808K1060
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier3.577.270 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Tcr2 Therapeutics Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TCRR / Tcr2 Therapeutics Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-05-25 TANG KEVIN C 50.000 1,7200 50.000 1,7200 86.000 0 1.7500 1.500 1,74
2023-05-12 TANG KEVIN C 6.183 1,9500 6.183 1,9500 12.057
2023-05-11 TANG KEVIN C 38.765 1,9500 38.765 1,9500 75.592
2023-05-10 TANG KEVIN C 6.774 1,9500 6.774 1,9500 13.209
2023-05-09 TANG KEVIN C 20.141 1,9500 20.141 1,9500 39.275
2023-05-08 TANG KEVIN C 57.073 1,9500 57.073 1,9500 111.292
2023-05-05 TANG KEVIN C 95.759 1,9000 95.759 1,9000 181.942
2023-05-05 TANG KEVIN C 71.064 1,9400 71.064 1,9400 137.864
2023-05-04 TANG KEVIN C 104.241 1,8600 104.241 1,8600 193.888

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TCRR / Tcr2 Therapeutics Inc Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TCRR / Tcr2 Therapeutics Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-05-22 MPM ASSET MANAGEMENT LLC 70.170 1,8800 70.170 1,8800 131.920 9 1.4800 -28.067 -21,28
2020-03-20 Gibson Neil W 648 7,9400 648 7,9400 5.145
2020-03-19 Gibson Neil W 3.140 7,4100 3.140 7,4100 23.267
2020-03-18 Gibson Neil W 3.120 6,8300 3.120 6,8300 21.310
2020-03-17 Gibson Neil W 3.009 6,4900 3.009 6,4900 19.528
2020-03-16 Gibson Neil W 17.723 6,6040 17.723 6,6040 117.043
2020-03-13 Gibson Neil W 52.000 6,5172 52.000 6,5172 338.894
2019-12-19 Jovan-Embiricos Morana 6.642 16,4714 6.642 16,4714 109.403
2019-12-19 Jovan-Embiricos Morana 35.323 16,4714 35.323 16,4714 581.819

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TCRR / Tcr2 Therapeutics Inc Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-02-14 2023-06-01 4 TANG KEVIN C By LP TCRR Common Stock J - Other I -4.394.800 0
2023-06-05 2023-06-01 4 MPM BioVentures 2014, L.P. TCRR Common Stock J - Other I -4.158.964 0
2023-06-05 2023-06-01 4 MPM SunStates Fund, L.P. TCRR Common Stock J - Other I -4.158.964 0
2023-06-05 2023-06-01 4 UBS Oncology Impact Fund L.P. TCRR Common Stock J - Other D -3.370.982 0
2023-06-05 2023-06-01 4 GADICKE ANSBERT TCRR Common Stock J - Other I -3.370.982 0
2023-06-05 2023-06-01 4 GADICKE ANSBERT TCRR Common Stock J - Other I -3.854.963 0
2023-06-05 2023-06-01 4 GADICKE ANSBERT TCRR Common Stock J - Other I -304.001 0
2023-06-01 2023-06-01 4 Cardama Alfonso Quintas TCRR Common Stock D - Sale to Issuer D -109.459 0
2023-06-01 2023-06-01 4 Olagunju Peter TCRR Common Stock D - Sale to Issuer D -24.092 0
2023-06-01 2023-06-01 4 Menzel Garry E TCRR Common Stock D - Sale to Issuer D -138.871 0
2023-06-01 2023-06-01 4 Menzel Garry E TCRR Common Stock D - Sale to Issuer I -132.730 0
2023-06-01 2023-06-01 4 Menzel Garry E TCRR Common Stock D - Sale to Issuer I -132.729 0
2023-06-01 2023-06-01 4 Justice Angela TCRR Common Stock D - Sale to Issuer D -48.745 0
2023-05-30 2023-05-25 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,7200 50.000 86 4.394.800
2023-05-24 2023-05-22 4 MPM ASSET MANAGEMENT LLC TCRR Common Stock S - Sale D 1,8800 -70.170 -132 304.001
2023-05-24 2023-05-22 4 MPM ASSET MANAGEMENT LLC TCRR Common Stock X - Other D 0,7400 178.269 132 374.171
2023-05-24 2023-05-22 4 GADICKE ANSBERT TCRR Common Stock S - Sale I 1,8800 -70.170 -132 304.001
2023-05-24 2023-05-22 4 GADICKE ANSBERT TCRR Common Stock X - Other I 0,7400 178.269 132 374.171
2023-05-15 2023-05-12 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9500 6.183 12 4.344.800
2023-05-15 2023-05-11 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9500 38.765 76 4.338.617
2023-05-10 2023-05-10 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9500 6.774 13 4.299.852
2023-05-10 2023-05-09 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9500 20.141 39 4.293.078
2023-05-10 2023-05-08 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9500 57.073 111 4.272.937
2023-05-05 2023-05-05 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9400 71.064 138 4.215.864
2023-05-05 2023-05-05 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,9000 95.759 182 4.144.800
2023-05-05 2023-05-04 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,8600 104.241 194 4.049.041
2023-05-05 2023-05-03 4 TANG KEVIN C By LP TCRR Common Stock P - Purchase I 1,8500 18.513 34 3.944.800
2023-05-05 3 TANG CAPITAL PARTNERS LP By LP TCRR Common Stock I 3.926.287
2022-12-13 2022-12-13 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,0610 -4.752 -5 109.459
2022-12-13 2022-12-12 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,0990 -4.586 -5 114.211
2022-12-13 2022-12-09 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,1300 -4.461 -5 118.797
2022-12-13 2022-12-13 4 Olagunju Peter TCRR Common Stock S - Sale D 1,0650 -1.659 -2 24.092
2022-12-13 2022-12-12 4 Olagunju Peter TCRR Common Stock S - Sale D 1,0970 -1.610 -2 25.751
2022-12-13 2022-12-09 4 Olagunju Peter TCRR Common Stock S - Sale D 1,1310 -1.561 -2 27.361
2022-12-13 2022-12-12 4 Justice Angela TCRR Common Stock S - Sale D 1,0630 -2.963 -3 48.745
2022-12-13 2022-12-12 4 Justice Angela TCRR Common Stock S - Sale D 1,0990 -2.865 -3 51.708
2022-12-13 2022-12-09 4 Justice Angela TCRR Common Stock S - Sale D 1,1280 -2.792 -3 54.573
2022-12-13 2022-12-13 4 Menzel Garry E TCRR Common Stock S - Sale D 1,0620 -11.000 -12 138.871
2022-12-13 2022-12-12 4 Menzel Garry E TCRR Common Stock S - Sale D 1,1000 -10.613 -12 149.871
2022-12-13 2022-12-09 4 Menzel Garry E TCRR Common Stock S - Sale D 1,1310 -10.325 -12 160.484
2022-12-09 2022-12-08 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,2560 -4.014 -5 123.258
2022-12-09 2022-12-07 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,2830 -3.928 -5 127.272
2022-12-09 2022-12-08 4 Justice Angela TCRR Common Stock S - Sale D 1,2550 -2.511 -3 57.365
2022-12-09 2022-12-07 4 Justice Angela TCRR Common Stock S - Sale D 1,2820 -2.457 -3 59.876
2022-12-09 2022-12-08 4 Menzel Garry E TCRR Common Stock S - Sale D 1,2540 -9.314 -12 170.809
2022-12-09 2022-12-07 4 Menzel Garry E TCRR Common Stock S - Sale D 1,2820 -9.111 -12 180.123
2022-12-09 2022-12-08 4 Olagunju Peter TCRR Common Stock S - Sale D 1,2530 -1.410 -2 28.922
2022-12-09 2022-12-07 4 Olagunju Peter TCRR Common Stock S - Sale D 1,2820 -1.378 -2 30.332
2022-12-07 2022-12-06 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,3340 -3.778 -5 131.200
2022-12-07 2022-12-05 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,3700 -3.686 -5 134.978
2022-12-07 2022-12-06 4 Menzel Garry E TCRR Common Stock S - Sale D 1,3490 -14.886 -20 189.234
2022-12-07 2022-12-05 4 Menzel Garry E TCRR Common Stock S - Sale D 1,3720 -8.530 -12 204.120
2022-12-07 2022-12-06 4 Olagunju Peter TCRR Common Stock S - Sale D 1,3300 -1.327 -2 31.710
2022-12-07 2022-12-05 4 Olagunju Peter TCRR Common Stock S - Sale D 1,3680 -1.291 -2 33.037
2022-12-07 2022-12-06 4 Justice Angela TCRR Common Stock S - Sale D 1,3340 -2.361 -3 62.333
2022-12-07 2022-12-05 4 Justice Angela TCRR Common Stock S - Sale D 1,3730 -2.302 -3 64.694
2022-12-05 2022-12-02 4 Justice Angela TCRR Common Stock S - Sale D 1,3910 -2.273 -3 66.996
2022-12-05 2022-12-01 4 Justice Angela TCRR Common Stock M - Exercise D 59.576 69.269
2022-12-05 2022-12-02 4 Menzel Garry E TCRR Common Stock S - Sale D 1,3900 -8.408 -12 212.650
2022-12-05 2022-12-01 4 Menzel Garry E TCRR Common Stock M - Exercise D 221.058 221.058
2022-12-05 2022-12-02 4 Cardama Alfonso Quintas TCRR Common Stock S - Sale D 1,3900 -3.636 -5 138.664
2022-12-05 2022-12-01 4 Cardama Alfonso Quintas TCRR Common Stock M - Exercise D 95.385 142.300
2022-12-05 2022-12-02 4 Olagunju Peter TCRR Common Stock S - Sale D 1,3870 -1.273 -2 34.328
2022-12-05 2022-12-01 4 Olagunju Peter TCRR Common Stock M - Exercise D 33.409 35.601
2022-08-26 2022-07-05 4 Menzel Garry E TCRR Common Stock G - Gift I 132.730 132.730
2022-08-26 2022-07-05 4 Menzel Garry E TCRR Common Stock G - Gift D -132.730 0
2022-08-26 2022-07-05 4 Menzel Garry E TCRR Common Stock G - Gift I 48.202 132.729
2022-08-26 2022-07-05 4 Menzel Garry E TCRR Common Stock G - Gift D -48.202 132.730
2022-08-26 2022-07-05 4 Menzel Garry E TCRR Common Stock G - Gift I 84.527 84.527
2022-08-26 2022-07-05 4 Menzel Garry E TCRR Common Stock G - Gift I -84.527 0
2022-03-18 2022-02-28 4 Menzel Garry E TCRR Common Stock A - Award D 2,3000 1.425 3 180.932
2022-03-18 2022-02-28 4 Justice Angela TCRR Common Stock A - Award D 2,3000 2.236 5 9.693
2022-01-12 2022-01-10 4 Harrison Rosemary TCRR Stock Option (Right to Buy) A - Award D 4,04 191.102 191.102
2021-12-10 2021-12-09 4 Webster Stephen W TCRR Stock Option (Right to Buy) A - Award D 5,21 12.100 12.100
2021-12-10 2021-12-09 4 Tomasello Shawn TCRR Stock Option (Right to Buy) A - Award D 5,21 12.100 12.100
2021-12-10 2021-12-09 4 Olagunju Peter TCRR Stock Option (Right to Buy) A - Award D 5,21 47.100 47.100
2021-12-10 2021-12-09 4 Cardama Alfonso Quintas TCRR Stock Option (Right to Buy) A - Award D 5,21 114.700 114.700
2021-12-10 2021-12-09 4 Cardama Alfonso Quintas TCRR Stock Option (Right to Buy) M - Exercise D 0,74 0,7400 43.000 32 31.582
2021-12-10 2021-12-09 4 Cardama Alfonso Quintas TCRR Common Stock M - Exercise D 0,7400 43.000 32 46.915
2021-12-10 2021-08-31 4 Cardama Alfonso Quintas TCRR Common Stock A - Award D 14,2600 164 2 3.915
2021-12-10 2021-12-10 4 Menzel Garry E TCRR Stock Option (Right to Buy) M - Exercise D 0,74 0,7400 5.946 4 138.031
2021-12-10 2021-12-10 4 Menzel Garry E TCRR Stock Option (Right to Buy) M - Exercise D 0,74 0,7400 169.054 125 0
2021-12-10 2021-12-09 4 Menzel Garry E TCRR Stock Option (Right to Buy) A - Award D 5,21 305.800 305.800
2021-12-10 2021-12-09 4 Menzel Garry E TCRR Common Stock M - Exercise D 0,7400 175.000 130 179.507
2021-12-10 2021-08-31 4 Menzel Garry E TCRR Common Stock A - Award D 14,2600 422 6 4.507
2021-12-10 2021-12-09 4 Hoos Axel TCRR Stock Option (Right to Buy) A - Award D 5,21 12.100 12.100
2021-12-10 2021-12-09 4 Justice Angela TCRR Stock Option (Right to Buy) A - Award D 5,21 76.500 76.500
2021-12-10 2021-08-31 4 Justice Angela TCRR Common Stock A - Award D 14,2600 379 5 7.457
2021-12-10 2021-12-09 4 Hofmeister Robert TCRR Stock Option (Right to Buy) A - Award D 5,21 100.000 100.000
2021-12-10 2021-12-09 4 Gibson Neil W TCRR Stock Option (Right to Buy) A - Award D 5,21 12.100 12.100
2021-12-10 2021-12-09 4 Hegde Priti TCRR Stock Option (Right to Buy) A - Award D 5,21 12.100 12.100
2021-12-10 2021-12-09 4 Allen Andrew R TCRR Stock Option (Right to Buy) A - Award D 5,21 12.100 12.100
2021-08-26 2021-08-25 4 Hegde Priti TCRR Stock Option (Right to Buy) A - Award D 16,02 24.968 24.968
2021-07-27 2021-07-26 4 Olagunju Peter TCRR Stock Option (Right to Buy) A - Award D 12,69 286.367 286.367
2021-07-27 3 Olagunju Peter TCRR Common Stock D 2.192
2021-04-02 2021-04-02 4 Justice Angela TCRR Stock Option (Right to Buy) M - Exercise D 14,81 -6.752 193.248
2021-04-02 2021-04-02 4 Justice Angela TCRR Common Stock M - Exercise D 14,8100 6.752 100 7.078
2021-03-08 2021-02-28 4 Cardama Alfonso Quintas TCRR Common Stock A - Award D 16,1245 708 11 3.751
2021-03-08 2020-08-31 4 Cardama Alfonso Quintas TCRR Common Stock A - Award D 10,0980 1.118 11 3.043
2021-03-08 2021-02-28 4 Justice Angela TCRR Common Stock A - Award D 16,1245 326 5 326
2021-03-08 2021-02-28 4 Menzel Garry E TCRR Common Stock A - Award D 16,1245 686 11 4.085
2021-03-08 2020-08-31 4 Menzel Garry E TCRR Common Stock A - Award D 10,0980 1.132 11 3.399
2021-02-04 2021-02-03 4 Tomasello Shawn TCRR Stock Option (Right to Buy) A - Award D 26,33 4.177 4.177
2021-02-04 2021-02-03 4 Tomasello Shawn TCRR Stock Option (Right to Buy) A - Award D 26,33 15.191 15.191
2020-12-23 2020-12-22 4 Hofmeister Robert TCRR Stock Option (Right to Buy) M - Exercise D 0,74 -7.000 28.732
2020-12-23 2020-12-22 4 Hofmeister Robert TCRR Common Stock M - Exercise D 0,7400 7.000 5 45.850
2020-12-16 2020-12-14 4 Somaiya Mayur Ian TCRR Stock Option (Right to Buy) M - Exercise D 5,88 2.000 102.558
2020-12-16 2020-12-14 4 Somaiya Mayur Ian TCRR Common Stock S - Sale D 35,0000 -2.000 -70 1.473
2020-12-16 2020-12-14 4 Somaiya Mayur Ian TCRR Common Stock M - Exercise D 5,8800 2.000 12 3.473
2020-12-11 2020-12-10 4 Allen Andrew R TCRR Stock Option (Right to Buy) A - Award D 31,83 12.100 12.100
2020-12-11 2020-12-10 4 Gibson Neil W TCRR Stock Option (Right to Buy) A - Award D 31,83 12.100 12.100
2020-12-11 2020-12-10 4 Justice Angela TCRR Stock Option (Right to Buy) A - Award D 31,83 67.000 67.000
2020-12-11 2020-12-10 4 Menzel Garry E TCRR Stock Option (Right to Buy) A - Award D 31,38 245.000 245.000
2020-12-11 2020-12-10 4 Baeuerle Patrick TCRR Stock Option (Right to Buy) A - Award D 31,83 12.100 12.100
2020-12-11 2020-12-10 4 Webster Stephen W TCRR Stock Option (Right to Buy) A - Award D 31,83 12.100 12.100
2020-12-11 2020-12-10 4 Hofmeister Robert TCRR Stock Option (Right to Buy) A - Award D 31,83 76.000 76.000
2020-12-11 2020-12-10 4 Cardama Alfonso Quintas TCRR Stock Option (Right to Buy) A - Award D 31,83 101.000 101.000
2020-12-11 2020-12-10 4 Somaiya Mayur Ian TCRR Stock Option (Right to Buy) A - Award D 31,83 92.000 92.000
2020-12-11 2020-12-10 4 Hoos Axel TCRR Stock Option (Right to Buy) A - Award D 31,83 12.100 12.100
2020-11-19 2020-11-17 4 Somaiya Mayur Ian TCRR Stock Option (Right to Buy) M - Exercise D 5,88 -2.000 104.558
2020-11-19 2020-11-17 4 Somaiya Mayur Ian TCRR Common Stock S - Sale D 30,0000 -1.666 -50 1.473
2020-11-19 2020-11-17 4 Somaiya Mayur Ian TCRR Common Stock S - Sale D 30,0000 -2.000 -60 3.139
2020-11-19 2020-11-17 4 Somaiya Mayur Ian TCRR Common Stock M - Exercise D 5,8800 2.000 12 5.139
2020-11-13 2020-11-12 4 Hofmeister Robert TCRR Stock Option (Right to Buy) M - Exercise D 0,74 -10.002 25.730
2020-11-13 2020-11-12 4 Hofmeister Robert TCRR Stock Option (Right to Buy) M - Exercise D 0,74 -9.998 12.348
2020-11-13 2020-11-12 4 Hofmeister Robert TCRR Common Stock S - Sale D 25,1000 -10.002 -251 38.850
2020-11-13 2020-11-12 4 Hofmeister Robert TCRR Common Stock M - Exercise D 0,7400 10.002 7 48.852
2020-11-13 2020-11-12 4 Hofmeister Robert TCRR Common Stock S - Sale D 25,1000 -9.998 -251 38.850
2020-11-13 2020-11-12 4 Hofmeister Robert TCRR Common Stock M - Exercise D 0,7400 9.998 7 48.848
2020-11-02 2020-10-29 4 Hofmeister Robert TCRR Stock Option (Right to Buy) M - Exercise D 0,74 -20.000 22.346
2020-11-02 2020-10-29 4 Hofmeister Robert TCRR Common Stock S - Sale D 19,1000 -20.000 -382 38.850
2020-11-02 2020-10-29 4 Hofmeister Robert TCRR Common Stock M - Exercise D 0,7400 20.000 15 58.850
2020-05-04 2020-04-30 4 Webster Stephen W TCRR Stock Option (Right to Buy) A - Award D 9,54 10.482 10.482
2020-04-15 2020-04-13 4 Hoos Axel TCRR Stock Option (Right to Buy) A - Award D 10,42 9.596 9.596
2020-03-27 2020-02-28 4 Somaiya Mayur Ian TCRR Common Stock A - Award D 10,1000 1.473 15 3.139
2020-03-27 2019-08-30 4 Somaiya Mayur Ian TCRR Common Stock A - Award D 12,7500 1.666 21 1.666
2020-03-27 2020-02-28 4 Cardama Alfonso Quintas TCRR Common Stock A - Award D 10,1000 1.082 11 1.925
2020-03-27 2019-08-30 4 Cardama Alfonso Quintas TCRR Common Stock A - Award D 12,7500 843 11 843
2020-03-27 2020-02-28 4 Menzel Garry E TCRR Common Stock A - Award D 10,1000 1.287 13 2.267
2020-03-27 2019-08-30 4 Menzel Garry E TCRR Common Stock A - Award D 12,7500 980 12 980
2020-03-27 2020-03-20 4 Gibson Neil W see footnote (2) TCRR Common Stock S - Sale I 7,9400 -648 -5 0
2020-03-27 2020-03-19 4 Gibson Neil W see footnote (2) TCRR Common Stock S - Sale I 7,4100 -3.140 -23 648
2020-03-27 2020-03-18 4 Gibson Neil W see footnote (2) TCRR Common Stock S - Sale I 6,8300 -3.120 -21 3.788
2020-03-27 2020-03-17 4 Gibson Neil W see footnote (2) TCRR Common Stock S - Sale I 6,4900 -3.009 -20 6.908
2020-03-27 2020-03-16 4 Gibson Neil W see footnote (2) TCRR Common Stock S - Sale I 6,6040 -17.723 -117 9.917
2020-03-27 2020-03-13 4 Gibson Neil W see footnote (2) TCRR Common Stock S - Sale I 6,5172 -52.000 -339 27.640
2020-03-27 2019-11-15 4 Gibson Neil W see footnote (2) TCRR Common Stock J - Other I -217.974 79.640
2020-03-27 2019-11-13 4 Gibson Neil W see footnote (2) TCRR Common Stock J - Other I -196.177 297.614
2020-03-27 2019-11-07 4 Gibson Neil W see footnote (2) TCRR Common Stock J - Other I -212.560 493.791
2019-12-26 2019-12-23 4 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock S - Sale I 15,4400 -84.907 -1.311 350.786
2019-12-26 2019-12-20 4 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock S - Sale I 15,1600 -32.022 -485 435.693
2019-12-20 2019-12-19 4 Menzel Garry E TCRR Stock Option (Right to Buy) A - Award D 16,10 168.000 168.000
2019-12-20 2019-12-19 4 Cardama Alfonso Quintas TCRR Stock Option (Right to Buy) A - Award D 16,10 -72.100 72.100
2019-12-20 2019-12-19 4 Gibson Neil W TCRR Stock Option (Right to Buy) A - Award D 16,10 5.000 5.000
2019-12-20 2019-12-19 4 Somaiya Mayur Ian TCRR Stock Option (Right to Buy) A - Award D 16,10 -50.000 50.000
2019-12-20 2019-12-19 4 Allen Andrew R TCRR Stock Option (Right to Buy) A - Award D 16,10 -5.000 5.000
2019-12-20 2019-12-19 4 Hofmeister Robert TCRR Stock Option (Right to Buy) A - Award D 16,10 50.000 50.000
2019-12-20 2019-12-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock J - Other I -13.847 161.024
2019-12-20 2019-12-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock J - Other I -586.153 713.723
2019-12-20 2019-12-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 16,4714 -35.323 -582 155.986
2019-12-20 2019-12-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 16,4714 -6.642 -109 82.575
2019-12-20 2019-12-18 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0060 -2.433 -41 191.309
2019-12-20 2019-12-18 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0060 -458 -8 89.217
2019-12-11 2019-12-11 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6525 -4.153 -73 1.299.876
2019-12-11 2019-12-11 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6525 -1.054 -19 330.238
2019-12-11 2019-12-11 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6525 -1.381 -24 432.319
2019-12-11 2019-12-11 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6525 -1.155 -20 361.665
2019-12-11 2019-12-10 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6232 -30.475 -537 1.304.029
2019-12-11 2019-12-10 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6232 -7.741 -136 331.292
2019-12-11 2019-12-10 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6232 -10.135 -179 433.700
2019-12-11 2019-12-10 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6232 -8.479 -149 362.820
2019-12-11 2019-12-09 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6511 -75.067 -1.325 1.334.504
2019-12-11 2019-12-09 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6511 -19.070 -337 339.033
2019-12-11 2019-12-09 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6511 -24.966 -441 443.835
2019-12-11 2019-12-09 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,6511 -20.886 -369 371.299
2019-10-24 2019-10-22 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 15,1571 -2.085 -32 1.409.571
2019-10-24 2019-10-22 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 15,1571 -530 -8 358.103
2019-10-24 2019-10-22 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 15,1571 -693 -11 392.185
2019-10-24 2019-10-22 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 15,1571 -580 -9 392.185
2019-09-24 2019-09-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,3114 -5.516 -95 1.411.656
2019-09-24 2019-09-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,3114 -1.401 -24 358.633
2019-09-24 2019-09-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,3114 -1.835 -32 469.464
2019-09-24 2019-09-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,3114 -351 -6 89.675
2019-09-24 2019-09-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,3114 -683 -12 174.871
2019-09-24 2019-09-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,3114 -1.535 -27 392.765
2019-09-24 2019-09-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,9354 -197.343 -3.539 1.417.172
2019-09-24 2019-09-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,9354 -50.134 -899 360.034
2019-09-24 2019-09-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,9354 -65.633 -1.177 471.299
2019-09-24 2019-09-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,9354 -12.537 -225 90.026
2019-09-24 2019-09-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,9354 -24.446 -438 175.554
2019-09-24 2019-09-20 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,9354 -54.907 -985 394.300
2019-09-05 2019-09-04 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,5548 -12.214 -214 102.563
2019-09-05 2019-09-03 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0142 -10.559 -180 114.777
2019-09-05 2019-08-29 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0068 -3.700 -63 125.336
2019-09-05 2019-08-28 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0061 -6.700 -114 129.036
2019-09-05 2019-08-27 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0113 -1.200 -20 135.736
2019-09-05 2019-08-26 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0104 -29.128 -495 136.936
2019-09-05 2019-08-23 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0000 -3 -0 166.064
2019-09-05 2019-08-22 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0300 -100 -2 166.067
2019-09-05 2019-08-21 4 Jovan-Embiricos Morana By Fund TCRR Common Stock S - Sale I 17,0000 -500 -8 166.167
2019-04-12 2019-04-11 4 Hofmeister Robert TCRR Stock Option (Right to Buy) A - Award D 16,11 127.512 127.512
2019-04-12 2019-04-11 4 Somaiya Mayur Ian TCRR Stock Option (Right to Buy) A - Award D 16,11 152.307 152.307
2019-04-12 2019-04-11 4 Menzel Garry E TCRR Stock Option (Right to Buy) A - Award D 16,11 486.106 486.106
2019-04-12 2019-04-11 4 Allen Andrew R TCRR Stock Option (Right to Buy) A - Award D 16,11 6.270 6.270
2019-04-12 2019-04-11 4 Cardama Alfonso Quintas TCRR Stock Option (Right to Buy) A - Award D 16,11 211.302 211.302
2019-04-12 2019-04-11 4 Gibson Neil W TCRR Stock Option (Right to Buy) A - Award D 16,11 6.270 6.270
2019-04-12 2019-04-11 4 Baeuerle Patrick TCRR Stock Option (Right to Buy) A - Award D 16,11 59.850 59.850
2019-02-21 2019-02-19 4 MPM BioVentures 2014, L.P. TCRR Series B Preferred Stock C - Conversion I -2.000.000 0
2019-02-21 2019-02-19 4 MPM BioVentures 2014, L.P. TCRR Series A Preferred Stock C - Conversion I -17.500.000 0
2019-02-21 2019-02-19 4 MPM BioVentures 2014, L.P. TCRR Common Stock P - Purchase I 15,0000 706.666 10.600 4.050.865
2019-02-21 2019-02-19 4 MPM BioVentures 2014, L.P. TCRR Common Stock C - Conversion I 322.901 3.344.199
2019-02-21 2019-02-19 4 MPM BioVentures 2014, L.P. TCRR Common Stock C - Conversion I 2.825.396 3.021.298
2019-02-21 2019-02-19 4 MPM SunStates Fund, L.P. TCRR Series B Preferred Stock C - Conversion I -2.000.000 0
2019-02-21 2019-02-19 4 MPM SunStates Fund, L.P. TCRR Series A Preferred Stock C - Conversion I -17.500.000 0
2019-02-21 2019-02-19 4 MPM SunStates Fund, L.P. TCRR Common Stock P - Purchase I 15,0000 706.666 10.600 4.050.865
2019-02-21 2019-02-19 4 MPM SunStates Fund, L.P. TCRR Common Stock C - Conversion I 322.901 3.344.199
2019-02-21 2019-02-19 4 MPM SunStates Fund, L.P. TCRR Common Stock C - Conversion I 2.825.396 3.021.298
2019-02-21 2019-02-19 4 UBS Oncology Impact Fund L.P. TCRR Series B Preferred Stock C - Conversion D -1.750.000 0
2019-02-21 2019-02-19 4 UBS Oncology Impact Fund L.P. TCRR Series A Preferred Stock C - Conversion D -15.000.000 0
2019-02-21 2019-02-19 4 UBS Oncology Impact Fund L.P. TCRR Common Stock P - Purchase D 15,0000 666.667 10.000 3.370.982
2019-02-21 2019-02-19 4 UBS Oncology Impact Fund L.P. TCRR Common Stock C - Conversion D 282.540 2.704.315
2019-02-21 2019-02-19 4 UBS Oncology Impact Fund L.P. TCRR Common Stock C - Conversion D 2.421.775 2.421.775
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Series B Preferred Stock C - Conversion I -2.500.000 0
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Series B Preferred Stock C - Conversion I -1.750.000 0
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Series B Preferred Stock C - Conversion I -2.540.500 0
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Series B Preferred Stock C - Conversion I -1.200.000 0
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Series A Preferred Stock C - Conversion I -10.000.001 0
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock P - Purchase I 15,0000 133.333 2.000 536.962
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock P - Purchase I 15,0000 166.667 2.500 449.207
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock P - Purchase I 15,0000 166.667 2.500 449.207
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock P - Purchase I 15,0000 200.000 3.000 200.000
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock C - Conversion I 403.629 403.629
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock C - Conversion I 282.540 282.540
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock C - Conversion I 410.168 410.168
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock C - Conversion I 193.742 193.742
2019-02-21 2019-02-19 4 Jovan-Embiricos Morana By Fund TCRR Common Stock C - Conversion I 1.614.515 1.614.515
2019-02-21 2019-02-19 4 Gibson Neil W TCRR Series B Preferred Stock C - Conversion I -4.375.000 0
2019-02-21 2019-02-19 4 Gibson Neil W TCRR Common Stock C - Conversion I 706.351 706.351
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series B Preferred Stock C - Conversion I -1.750.000 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series B Preferred Stock C - Conversion I -217.500 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series B Preferred Stock C - Conversion I -1.586.623 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series B Preferred Stock C - Conversion I -105.825 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series B Preferred Stock C - Conversion I -32.500 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series B Preferred Stock C - Conversion I -57.552 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series A Preferred Stock C - Conversion I -15.000.000 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series A Preferred Stock C - Conversion I -2.174.998 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series A Preferred Stock C - Conversion I -13.599.621 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series A Preferred Stock C - Conversion I -907.073 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series A Preferred Stock C - Conversion I -325.002 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Series A Preferred Stock C - Conversion I -493.306 0
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock P - Purchase I 15,0000 1.373.333 20.600 1.569.235
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 282.540 2.704.315
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 35.115 386.270
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 256.163 2.451.844
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 17.085 163.532
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 5.247 57.716
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 9.291 88.935
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 2.421.775 2.421.775
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 351.155 351.155
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 2.195.681 2.195.681
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 146.447 146.447
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 52.469 52.469
2019-02-21 2019-02-19 4 GADICKE ANSBERT TCRR Common Stock C - Conversion I 79.644 79.644
2019-02-21 2019-02-19 4 Upnorth Investment Ltd By Upnorth Investment Limited TCRR Series B Preferred Stock C - Conversion I -10.000.000 0
2019-02-21 2019-02-19 4 Upnorth Investment Ltd By Upnorth Investment Limited TCRR Series A Preferred Stock C - Conversion I -2.000.000 0
2019-02-21 2019-02-19 4 Upnorth Investment Ltd By Upnorth Investment Limited TCRR Common Stock P - Purchase I 15,0000 200.000 3.000 2.137.419
2019-02-21 2019-02-19 4 Upnorth Investment Ltd By Upnorth Investment Limited TCRR Common Stock C - Conversion I 1.614.517 1.937.419
2019-02-21 2019-02-19 4 Upnorth Investment Ltd By Upnorth Investment Limited TCRR Common Stock C - Conversion I 322.902 322.902
2019-02-21 2019-02-19 4 Redmile Group, LLC See note TCRR Series B Redeemable Convertible Preferred Stock C - Conversion I -5.000.000 0
2019-02-21 2019-02-19 4 Redmile Group, LLC See note TCRR Common Stock C - Conversion I 807.256 807.256
2019-02-13 3 Finer Mitchell H. TCRR Common Stock D 73.462
2019-02-13 3 Finer Mitchell H. TCRR Common Stock D 73.462
2019-02-13 3 Finer Mitchell H. TCRR Common Stock D 73.462
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 637.100
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 637.100
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 521.167
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 712.593
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 637.100
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 521.167
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 712.593
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 521.167
2019-02-13 3 Baeuerle Patrick By APAK Solutions GmbH TCRR Common Stock I 712.593
2019-02-13 3 Menzel Garry E TCRR Common Stock I 169.054
2019-02-13 3 Menzel Garry E TCRR Common Stock I 169.054
2019-02-13 3 Menzel Garry E TCRR Common Stock I 169.054
2019-02-13 3 GADICKE ANSBERT TCRR Common Stock I 391.804
2019-02-13 3 GADICKE ANSBERT TCRR Common Stock I 391.804
2019-02-13 3 GADICKE ANSBERT TCRR Common Stock I 391.804
2019-02-13 3 Hofmeister Robert TCRR Common Stock D 53.563
2019-02-13 3 Hofmeister Robert TCRR Common Stock D 62.987
2019-02-13 3 Hofmeister Robert TCRR Common Stock D 53.563
2019-02-13 3 Hofmeister Robert TCRR Common Stock D 62.987
2019-02-13 3 Hofmeister Robert TCRR Common Stock D 53.563
2019-02-13 3 Hofmeister Robert TCRR Common Stock D 62.987
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM ASSET MANAGEMENT LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM SunStates GP Managing Member LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM SunStates GP Managing Member LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM SunStates GP Managing Member LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM SunStates GP Managing Member LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM SunStates GP Managing Member LLC TCRR Common Stock I 391.804
2019-02-13 3 MPM SunStates GP Managing Member LLC TCRR Common Stock I 391.804
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista